Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Diagnostic Approach in Large B-Cell Lymphomas According to the Fifth World Health Organization and International Consensus Classifications and a Practical Algorithm in Routine Practice.
Zanelli M, Sanguedolce F, Zizzo M, Ricci S, Bisagni A, Palicelli A, Fragliasso V, Donati B, Broggi G, Boutas I, Koufopoulos N, Foroni M, Coppa F, Morini A, Parente P, Zuccalà V, Caltabiano R, Fabozzi M, Cimino L, Neri A, Ascani S. Zanelli M, et al. Among authors: fragliasso v. Int J Mol Sci. 2024 Dec 9;25(23):13213. doi: 10.3390/ijms252313213. Int J Mol Sci. 2024. PMID: 39684922 Free PMC article. Review.
Mosunetuzumab for the treatment of follicular lymphoma.
Labanca C, Martino EA, Vigna E, Bruzzese A, Mendicino F, De Luca P, Lucia E, Olivito V, Fragliasso V, Neri A, Morabito F, Gentile M. Labanca C, et al. Among authors: fragliasso v. Expert Opin Biol Ther. 2024 Oct;24(10):1039-1048. doi: 10.1080/14712598.2024.2404079. Epub 2024 Sep 16. Expert Opin Biol Ther. 2024. PMID: 39259182 Review.
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma.
Puccio N, Manzotti G, Mereu E, Torricelli F, Ronchetti D, Cumerlato M, Craparotta I, Di Rito L, Bolis M, Traini V, Manicardi V, Fragliasso V, Torrente Y, Amodio N, Bolli N, Taiana E, Ciarrocchi A, Piva R, Neri A. Puccio N, et al. Among authors: fragliasso v. Haematologica. 2024 Dec 1;109(12):4040-4055. doi: 10.3324/haematol.2024.285470. Haematologica. 2024. PMID: 38988264 Free PMC article.
Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.
Zanelli M, Fragliasso V, Parente P, Bisagni A, Sanguedolce F, Zizzo M, Broggi G, Ricci S, Palicelli A, Foroni M, Gozzi F, Gentile P, Morini A, Koufopoulos N, Caltabiano R, Cimino L, Fabozzi M, Cavazza A, Neri A, Ascani S. Zanelli M, et al. Among authors: fragliasso v. Int J Mol Sci. 2024 Jun 11;25(12):6447. doi: 10.3390/ijms25126447. Int J Mol Sci. 2024. PMID: 38928153 Free PMC article. Review.
Momelotinib in myelofibrosis.
Bruzzese A, Martino EA, Labanca C, Mendicino F, Lucia E, Olivito V, Zimbo A, Fragliasso V, Neri A, Morabito F, Vigna E, Gentile M. Bruzzese A, et al. Among authors: fragliasso v. Expert Opin Pharmacother. 2024 Apr;25(5):521-528. doi: 10.1080/14656566.2024.2343780. Epub 2024 Apr 18. Expert Opin Pharmacother. 2024. PMID: 38623844 Review.
HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.
Tameni A, Mallia S, Manicardi V, Donati B, Torricelli F, Vitale E, Salviato E, Gambarelli G, Muccioli S, Zanelli M, Ascani S, Martino G, Sanguedolce F, Sauta E, Tamagnini I, Puccio N, Neri A, Ciarrocchi A, Fragliasso V. Tameni A, et al. Among authors: fragliasso v. Nucleic Acids Res. 2024 Jun 24;52(11):6171-6182. doi: 10.1093/nar/gkae239. Nucleic Acids Res. 2024. PMID: 38597676 Free PMC article.
Chronic myeloproliferative neoplasms with concomitant CALR mutation and BCR::ABL1 translocation: diagnostic and therapeutic implications of a rare hybrid disease.
Zanelli M, Fragliasso V, Loscocco GG, Sanguedolce F, Broggi G, Zizzo M, Palicelli A, Ricci S, Ambrogi E, Martino G, Aversa S, Coppa F, Gentile P, Gozzi F, Caltabiano R, Koufopoulos N, Asaturova A, Cimino L, Cavazza A, Orcioni GF, Ascani S. Zanelli M, et al. Among authors: fragliasso v. Front Cell Dev Biol. 2024 Mar 26;12:1391078. doi: 10.3389/fcell.2024.1391078. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38596359 Free PMC article. Review.
Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination.
Zanelli M, Bisagni A, Sanguedolce F, Broggi G, Fragliasso V, Zizzo M, Palicelli A, Martino G, Cresta C, Caprera C, Corsi M, Gentile P, Gozzi F, Trombetta D, Parente P, Caltabiano R, Koufopoulos N, Cimino L, Cavazza A, Fraternali Orcioni G, Ascani S. Zanelli M, et al. Among authors: fragliasso v. Front Oncol. 2024 Jan 12;13:1329298. doi: 10.3389/fonc.2023.1329298. eCollection 2023. Front Oncol. 2024. PMID: 38282677 Free PMC article. Review.
Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential Diagnoses.
Zanelli M, Sanguedolce F, Zizzo M, Fragliasso V, Broggi G, Palicelli A, Loscocco GG, Cresta C, Caprera C, Corsi M, Martino G, Bisagni A, Marchetti M, Koufopoulos N, Parente P, Caltabiano R, Ascani S. Zanelli M, et al. Among authors: fragliasso v. Cancers (Basel). 2023 Aug 2;15(15):3928. doi: 10.3390/cancers15153928. Cancers (Basel). 2023. PMID: 37568745 Free PMC article. Review.
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification.
Favasuli VK, Ronchetti D, Silvestris I, Puccio N, Fabbiano G, Traini V, Todoerti K, Erratico S, Ciarrocchi A, Fragliasso V, Giannandrea D, Tumiatti F, Chiaramonte R, Torrente Y, Finelli P, Morelli E, Munshi NC, Bolli N, Neri A, Taìana E. Favasuli VK, et al. Among authors: fragliasso v. Haematologica. 2024 Jan 1;109(1):231-244. doi: 10.3324/haematol.2023.283274. Haematologica. 2024. PMID: 37439377 Free PMC article.
29 results